News
All news from Vismederi Holding
VisMederi signs vaccine research partnership with GCCL at World Vaccine Congress 2026
VisMederi announces the signing of a Memorandum of Understanding with Global Clinical Central Lab, an international company specializing in clinical trial services, at the World Vaccine Congress 2026, one of the leading global events dedicated to the vaccine...
Universal influenza vaccine candidate, collaboration with Sumitomo Pharma Co., Ltd. and Japan’s National Institutes of Biomedical Innovation Health and Nutrition (NIBN)
VisMederi highlighted its collaboration with Sumitomo Pharma Co., Ltd. and Japan’s National Institutes of Biomedical Innovation, Health and Nutrition (NIBN) in the European Phase 1 clinical programme evaluating a universal influenza vaccine candidate formulated...
VisMederi is a partner in the EU-selected NOFLU consortium supporting early clinical development of a next-generation pandemic influenza vaccine
VisMederi is a partner in NOFLU, a European consortium selected by the European Union to support the early clinical development of a next-generation pandemic influenza vaccine. The project is coordinated by NIVI Development, the development arm of the Novo Nordisk...
VisMederi steps up Nipah readiness as India reports a new signal in West Bengal.
VisMederi is reinforcing its strategic role as a reference laboratory for global epidemic and pandemic preparedness, with a specific focus over the past year on the development, standardization, and validation of serological testing for Nipah virus (NiV). The...
VisMederi drives progress toward the 100 Days Mission through CEPI’s world-leading network
VisMederi emphasizes the importance of its role within Coalition for Epidemic Preparedness Innovations (CEPI)’s Centralized Laboratory Network, the world’s largest network dedicated to standardising the assessment of epidemic and pandemic vaccine candidates. In the...
New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”
A new scientific paper authored by Emanuele Montomoli and Claudia Maria Trombetta has just been published in Expert Review of Vaccines: “High-dose influenza vaccine: enhanced protection for the elderly.” The review highlights the added value of the high-dose...